PSAP and prostate neoplasm: Among 127 surveyed extra-prostatic tumor entities, PSAP positivity was only observed in one of 129 (0.8%) gastric adenocarcinomas and in 3 of 94 (3.2%) pancreatic neuroendocrine tumors.